Słowakiewicz Katarzyna, Perenc Małgorzata, Sieroszewski Piotr
Klinika Medycyny Płodu i Ginekologii, I Katedra Ginekologii i Połoznictwa w Łodzi.
Ginekol Pol. 2010 May;81(5):352-7.
PIH and IUGR are serious complications in the third trimester of pregnancy. Many publications claim a connection between false positive prenatal tests and subsequent occurrence of PIH and IUGR.
The aim of the study was to estimate the usefulness of the biochemical markers of fetal defects and uterine Doppler examination in predicting PIH and IUGR in the third trimester of pregnancy.
We examined 156 pregnant patients in The Department of the Fetal Medicine and Gynecology Medical University of Lodz, between 2006-2009. In case of each pregnant woman we estimated biochemical markers in the first (PAPP-A + beta-hCG) and second trimester (AFP, beta-hCG, uE3 - triple test). Each patient underwent three ultrasonographic examinations in the first, second and third trimester (between 11-13, 15-20, and 22-27 weeks gestation, respectively) with uterine artery Doppler examination. We monitored these pregnancies for PIH and IUGR and divided them into three groups: 28 patients with PIH (study group 1), 14 patients with IUGR (study group 2), and 114 patients with uncomplicated pregnancies (controls).
In both study groups we observed: higher concentration of beta-hCG, higher percentage of the positive biochemical prenatal tests and abnormal uterine artery Doppler waveform. Positive triple test was the strongest predictor of PIH and IUGR (PPV=60.87% for PIH and PPV = 30.77% for IUGR).
Biochemical markers and abnormal uterine artery Doppler waveform are associated with PIH and IUGR. These parameters can be the base for the test identifying pregnant patients with high risk of PIH and IUGR.
妊娠期高血压疾病(PIH)和胎儿生长受限(IUGR)是妊娠晚期的严重并发症。许多出版物声称产前检查假阳性与随后发生的PIH和IUGR之间存在关联。
本研究的目的是评估胎儿缺陷生化标志物和子宫多普勒检查在预测妊娠晚期PIH和IUGR方面的实用性。
2006年至2009年期间,我们在罗兹医科大学胎儿医学与妇科学系检查了156名孕妇。对于每位孕妇,我们在孕早期(妊娠相关血浆蛋白-A +β-人绒毛膜促性腺激素)和孕中期(甲胎蛋白、β-人绒毛膜促性腺激素、游离雌三醇——三联试验)评估生化标志物。每位患者在孕早期、孕中期和孕晚期(分别在妊娠11 - 13周、15 - 20周和22 - 27周之间)接受三次超声检查及子宫动脉多普勒检查。我们监测这些妊娠情况以观察PIH和IUGR,并将她们分为三组:28例PIH患者(研究组1),14例IUGR患者(研究组2),以及114例无并发症妊娠的患者(对照组)。
在两个研究组中我们均观察到:β-人绒毛膜促性腺激素浓度较高、生化产前检查阳性百分比更高以及子宫动脉多普勒波形异常。三联试验阳性是PIH和IUGR最强的预测指标(PIH的阳性预测值为60.87%,IUGR的阳性预测值为30.77%)。
生化标志物和异常子宫动脉多普勒波形与PIH和IUGR相关。这些参数可作为识别有PIH和IUGR高风险孕妇的检测基础。